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Table 1
Variable
Carotid Artery
Stenting (n¼33)
Carotid
Endarterectomy
(n¼32) p Value
Age 71.5110.31 69.8111.07 0.421
Male gender 25 (75%) 31 (96%) 0.064
Symptomatic
Amaurosis Fugax 5 (15%) 6 (19%) 0.699
TIA 25 (76%) 26 (82%) 0.590
Stroke 3 (9%) 0 0.081
Diabetes Mellitus 11 (33%) 20 (62%) <0.05
Hypertension 25 (76%) 21 (66%) 0.369
Smoker 20 (61%) 25 (78%) 0.126
CAD 23 (70%) 16 (50%) 0.105
Previous Myocardial
_Infarction
13 (39%) 9 (28%) 0.337
Previous CABG 5 (15%) 5 (16%) 0.958
Previous PTCA 15 (45%) 14 (43%) 0.890
Atrial Fibrillation 5 (15%) 1 (3%) <0.05
Preprocedural
Medication
ASA 25 (76%) 32(100%) 0.157
Clopidogrel 23 (70%) 19 (59%) 0.389
Antihypertensive 30 (91%) 21(65%) <0.05
Statin 33 (100%) 32(100%) 1
CAD: Coronary artery disease, CABG: Coronary artery by-pass graft surgery, PTCA: Percuta-
neous transluminal coronary angioplasty, ASA: Acetyl salicylic acid
Table 2
Variable CAS CEA p Value
Periprocedural
Transient Ischemic
Attack
3 (9.1%) 2 (6.2%) 0.721
Myocardial
Infarction
0 0 -
Stroke 2(6.0%) 0 0.081
Death 0 2 (6.2%) 0.072
Postprocedural
Transient Ischemic 3 (9.0%) 0 <0.05
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Objectıves: Coronary artery ﬁstula (CAF) in adults is a rare form of coronary artery
anomalies. It is often diagnosed incidentally during coronary angiograms. The aim of
this study was to evaluate clinical and angiographic characteristics of adult patients
with CAF.
Methods: We retrospectively reviewed the database of 70850 patients who had
undergone coronary angiography at 5 different invasive cardiology centers in the
southeastern region of Turkey. Among them there were 56 patients with CAF (39
males and 17 females, mean age: 63.710.4 years). Demographic data and clinical
evaluation, and cardiac catheterization reports were reviewed from medical records.
Results: A total of 58 ﬁstulas were detected in 56 patients; two patients (4%) had
bilateral ﬁstulas originating from both left coronary artery and right coronary artery. In
our angiographic series, CAF prevalence was 0.079%. Dyspnea on exertion and / or
angina pectoris was the most common symptoms (69%). There were 15 (29%)
patients with concomitant obstructive coronary artery disease. Coronary artery ﬁstulas
were originated mainly from left anterior descending artery (n¼30, 58%). Others were
originating from right coronary artery (n¼15, %29), circumﬂex artery (n¼6, 11%),
and right sinus of Valsalva (n¼3, 6%). In four patients (n¼4, 8%), there were multiple
micro ﬁstula drop into the left ventricle.
Conclusıons: In our angiographic series, the prevalence of CAF was 0.079%. The
most common site of origin was left anterior descending artery.
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Background and Aım: Large randomised trials have established carotid endarter-
ectomy (CEA) as the standard treatment for symptomatic severe carotid artery
stenosis. Carotid artery stenting (CAS) has been increasingly used for possible
alternative treatment to CEA. In this study we aimed to compare the periprocedural
and one year fallow-up outcomes of CAS with those of CEA among patients with
symptomatic extracranial carotid stenosis in patients from eastern Turkey.
Methods: The hospital records of all patients who underwent carotid artery revas-
cularization between May 2011 and May 2012 were retrospectively reviewed. Patients
were divided into 2 groups based on the type of carotid revascularization performed,
namely CEA or CAS. Comparisons between the 2 groups were made with respect to
pre-procedural risk factors, periprocedural and post-procedural transient ischemic
attack (TIA), myocardial infarction (MI), stroke and death rates. Cumulative survival
for both groups was also analysed.
Results: Thirty-two CEA procedures were performed by vascular surgeons and 33
CAS procedures were performed by cardiologists during the time period being
evaluated. All of the operations and CAS were performed for symptomatic carotid
occlusive disease. Baseline characteristics were similar between both treatment groups
except for antihypertensive usage, the incidence of Diabetes Mellitus, and Atrial
Fibrillation. The total 30-day perioperative TIA and death rates for CEA were similar.
Stroke and periprocedural MI was not observed. No signiﬁcant differences were found
with respect to 30-day mortality and neurologic morbidity endpoints. In the post-
procedure 1 year fallow-up when both groups were analysed, only TIA was observed
signiﬁcantly higher in CAS group, the other endpoints did not differ signiﬁcantly. One
year cumulative survival did not differ in the CEA or CAS groups according to
calendar period of admission (Log Rank p¼0.300).
Conclusıon: In our trial of patients with severe symptomatic carotid artery stenosis no
signiﬁcant difference could be shown in periprocedural outcomes, post-procedural
outcomes except TIA, and in cumulative survival with one year fallow-up between
patients who underwent carotid artery stenting and those who underwent endarter-
ectomy. CAS is a safe and efﬁcacious alternative for the treatment of symptomatic
carotid artery stenosis.Attack
Myocardial
Infarction
2 (6.0%) 2(6.2%) 0.963
Stroke 2 (6.0%) 3 (9.3%) 0.357
Death 1 (3,0%) 3 (9.3%) 0.137
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